The synthesis of retatrutide, a novel dual activator targeting both GLP-1 and GIP receptors, requires a complex several-stage synthetic process. Initial routes focused on amino acid chain fragment coupling, utilizing solid-phase creation methodologies to build the long protein sequence. Subsequent study has explored various approaches, including en